During the past decade, Site 520: University of Udayana/Sanglah Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Site 520: University of Udayana/Sanglah Hospital" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator, "National Institute of Health Research and Development, Ministry of Health Republic of Indonesia" with 1 trials as a collaborator and "The National Institute of Allergy and Infectious Diseases, United States" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Site 520: University of Udayana/Sanglah Hospital" are "HIV" (1 trials), "Infectious Disease" (1 trials), "Lung Tuberculosis" (1 trials) and "MDR TB" (1 trials). Many other conditions were trialed in "Site 520: University of Udayana/Sanglah Hospital" in a lesser frequency.

Most popular intervention types in "Site 520: University of Udayana/Sanglah Hospital" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "No Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Site 520: University of Udayana/Sanglah Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Site 520: University of Udayana/Sanglah Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Site 520: University of Udayana/Sanglah Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Site 520: University of Udayana/Sanglah Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".